DCC (Deleted in Colorectal Cancer) Inactivation in Hematological Malignancies

References

• Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249–270
   PubMed Web of Science ®Google Scholar
• Marshall C. J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M. M., Bos J. L. Genetic alterations during colorectaltumor development. N. Engl. J. Med 1988; 319: 525–532
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767
   PubMed Web of Science ®Google Scholar
• Sawyers C. L., Denny C. T., Witte O. N. Leukemia and the disruption of the normal hematopoiesis. Cell 1991; 64: 337–350
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Cho J. R., Nigro J. M., Kern S. E., Simons J. W., Ruppert J. M., Hamilton S. R., Preisinger A. C., Thomas G., Kinzler K., Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancer. Science 1990; 247: 49–56
   PubMed Web of Science ®Google Scholar
• Devilee P., van Vliet M., Kuipers Dijkshoorn N., Pearson P. L., Cornelisse C. J. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?. Oncogens 1991; 6: 311–315
   PubMed Web of Science ®Google Scholar
• Kikuchi-Yanoshita R., Konishi M., Fukunari H., Tanaka K., Miyaki M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992; 52: 3801–3803
   PubMed Web of Science ®Google Scholar
• Miyake S., Nagai K., Yoshino K., Oto M., Endo M., Yuasa Y. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 1994; 54: 3007–3010
   PubMed Web of Science ®Google Scholar
• Höhne M. W., Halatsch M. E., Kahl G. F., Weinel R. J. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 1992; 52: 2616–2619
   PubMed Web of Science ®Google Scholar
• Chenevix-Trench G., Leary J., Kerr J., Michel J., Kefford R., Hurst T., Parsons P. G., Friedlander M., Khoo S. K. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 1992; 7: 1059–1065
   PubMed Web of Science ®Google Scholar
• Gao X., Honn K. V., Grignon D., Sakr W., Chen Y. Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 1993; 53: 2723–2727
   PubMed Web of Science ®Google Scholar
• Scheck A. C., Coons S. W. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res 1993; 53: 5605–5609
   PubMed Web of Science ®Google Scholar
• Porfiri E., Secker-Walker L. M., Hoffbrand A. V., Hancock J. F. DCC tumor suppressor gene is inactivated in hematological malignancies showing monosomy 18. Blood 1993; 81: 2696–2701
   PubMed Web of Science ®Google Scholar
• Miyake K., Inokuchi K., Dan K., Nomura T. Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 1993; 82: 972–930
   Google Scholar
• Miyake K., Inokuchi K., Dan K., Nomura T. Expression of the DCC gene in myelodysplastic syndromes and overt leukemia. Leuk. Res 1993; 17: 785–788
   PubMed Web of Science ®Google Scholar
• Lane D. P., Benchimol S. p53: oncogene or antioncogene?. Genes Dev 1990; 4: 1–18
   PubMed Web of Science ®Google Scholar
• Knudson A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Mitelman F. Catalog of chromosomal aberration in cancer. Liss, New York, NY 1991; 1341–1389
   Google Scholar
• Fenaux P., Jonveaux P., Quiquandon I., Laï J. L., Pignon J. M., Loucheux-Lefebvre M. H., Bauters F., Berger R., Kerckaert J. P. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652–1657
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Rydell R. E., Oken M. M., Arnesen M. A., Mayer M. G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721–1730
   PubMed Web of Science ®Google Scholar
• Younes A., Jendiroba D., Engel H., Escudier S., Khoury P., Katz R., Hill D., Rodriguez M. A., Cabanillas F., Andreeff M. Monosomy 18 is more common in lymphoid malignancies with high incidence of bone marrow and peripheral blood involvement. Blood 1993; 82: 44a, 165, (Supl. 1) abst.
   Web of Science ®Google Scholar
• Nigro J. M., Cho K. R., Fearon E. R., Kern S. E., Ruppert M. J., Oliner J. D., Kinzler K. W., Vogelstein B. Scrambled exons. Cell 1991; 64: 607–613
   PubMed Web of Science ®Google Scholar
• Jacobs A. Oncogenes in the myelodysplastic Syndrome. Blood Reviews 1989; 3: 105–109
   PubMed Web of Science ®Google Scholar
• Solomon E., Borrow J., Goddard A. D. Chromosome aberrations and cancer. Science 1991; 254: 1153–1160
   PubMed Web of Science ®Google Scholar
• Hedrick L., Cho K. R., Fearon E. R., Wu T. C., Kinzler K. W., Vogelstein B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 1994; 8: 1174–1183
   PubMed Web of Science ®Google Scholar
• Edelman G. M. Morphoregulatory molecules. Biochemistry 1988; 27: 3533–3543
   PubMed Web of Science ®Google Scholar
• Hedrick L., Cho K. R., Boyd J., Risinger J., Vogelstein B. DCC: a tumor suppressor gene expressed on the cell surface. Cold Spring Harbor Symp. Quant. Biol 1992; 57: 345–351
   PubMedGoogle Scholar
• Doherty P., Walsh S. F. Cell adhesion molecules, second messengers and axonal growth. Curr. Opin. Neurobiol 1992; 2: 595–601
   PubMedGoogle Scholar
• Lawlor K. G., Narayanan R. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Differ 1992; 3: 609–616
   PubMedGoogle Scholar
• Frei T., von Bohlen und Halbach F., Wille W., Schachner M. Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions. J. Cell Biol 1992; 118: 177–194
   PubMed Web of Science ®Google Scholar
• Schuch U., Lohse M. J., Schachner M. Neural cell adhesion molecules influence second messenger systems. Neuron 1989; 3: 13–20
   PubMed Web of Science ®Google Scholar
• Atashi J. R., Klinz S. G., Ingraham C. A., Matten W. T., Schachner M., Maness P. Neural cell adhesion molecules modulate tyrosine phosphorylation of tubulin in nerve growth cone membrane. Neuron 1992; 8: 831–842
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Chang C., Azuma M., Ruitenberg J. J., Hemperly J., Phillips J. H. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J. Immunol 1991; 146: 4421–4426
   PubMed Web of Science ®Google Scholar
• Johnson J. P. Cell adhesion molecules of the immunoglobulin gene superfamily and their role in malignant transformation and progression to metastatic disease. Cancer and Metastasis Reviews 1991; 10: 11–22
   PubMed Web of Science ®Google Scholar
• Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Cur. Opin. Cell Biol 1993; 5: 806–811
   PubMed Web of Science ®Google Scholar
• Schwartz M. A. Signaling by integrins: implications for tumorigenesis. Cancer Res 1993; 53: 1503–1506
   PubMed Web of Science ®Google Scholar
• Narayanan R., Lawlor K. G., Schaapveld R. Q. J., Cho K. R., Vogelstein B., Bui Vinh Tran P., Osborne M. P., Telang N. T. Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 1992; 7: 553–561
   PubMed Web of Science ®Google Scholar
• Tanaka K., Oshimura M., Kikuchi R., Seki M., Hayashi T., Miyaki M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 1991; 349: 340–342
   PubMed Web of Science ®Google Scholar
• Goyette M. C., Cho K., Fasching C. L., Levy D. B., Kinzler K. W., Paraskeva C., Vogelstein B., Stanbridge E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell Biol 1992; 12: 1387–1395
   PubMed Web of Science ®Google Scholar
• Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844–2853
   PubMed Web of Science ®Google Scholar
• Long M. W. Blood cell cytoadhesion molecules. Exp. Hematol 1992; 20: 288–301
   PubMed Web of Science ®Google Scholar
• Whetton A. D., Dexter M. T. Influence of growth factors and substrates on differentiation of haemopoietic stem cells. Cur. Opin. Cell Biol 1993; 5: 1044–1049
   PubMed Web of Science ®Google Scholar
• Dittel B. N., McCarthy J. B., Wayner E. A., LeBien T. W. Regulation of human B cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993; 81: 2272–2282
   PubMed Web of Science ®Google Scholar
• Texido J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of β1 and β2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J. Clin. Investig 1992; 90: 358–357
   PubMed Web of Science ®Google Scholar
• Roberts R., Gallagher J., Spooncer E., Allen T. D., Bloomfield F., Dexter T. M. Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332: 376–378
   PubMed Web of Science ®Google Scholar
• Liesveld J. L., Winslow J. M., Frediani K. E., Ryan D. H., Abbot C. N. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112–121
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman M. J., Creaves M. F. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342–344
   PubMed Web of Science ®Google Scholar
• Reuss-Borst M. A., Steinke B., Waller H. D., Buhring H. D., Muller C. A. Phenotypic and clinical heterogeneity of CD56-positive acute non-lymphoblastic leukemia. Ann. Hematol 1992; 64: 78–82
   PubMed Web of Science ®Google Scholar